HER2-mediated effects on EGFR endosomal sorting: analysis of biophysical mechanisms.
暂无分享,去创建一个
Douglas Lauffenburger | H Steven Wiley | D. Lauffenburger | H. Wiley | B. Hendriks | Bart S Hendriks | H. Steven Wiley | Bart S. Hendriks
[1] Y. Yarden,et al. The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand‐receptor interactions , 1997, FEBS letters.
[2] N. Hynes,et al. ErbB‐2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling , 1997, The EMBO journal.
[3] H. Earp,et al. Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research , 1995, Breast Cancer Research and Treatment.
[4] A. Ullrich,et al. Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product. , 1990, Cancer research.
[5] J. Welsh,et al. Ligand-induced transformation by a noninternalizing epidermal growth factor receptor. , 1990, Science.
[6] Alan Wells,et al. Membrane Proximal ERK Signaling Is Required for M-calpain Activation Downstream of Epidermal Growth Factor Receptor Signaling* , 2001, The Journal of Biological Chemistry.
[7] D A Lauffenburger,et al. Postendocytic trafficking of epidermal growth factor-receptor complexes is mediated through saturable and specific endosomal interactions. , 1994, The Journal of biological chemistry.
[8] H. Wiley,et al. Structural Aspects of the Epidermal Growth Factor Receptor Required for Transmodulation of erbB-2/neu* , 1997, The Journal of Biological Chemistry.
[9] H. Wiley,et al. Anomalous binding of epidermal growth factor to A431 cells is due to the effect of high receptor densities and a saturable endocytic system , 1988, The Journal of cell biology.
[10] P. Seeburg,et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells , 1984, Nature.
[11] D. Slamon,et al. Transformation mediated by the human HER-2 gene independent of the epidermal growth factor receptor. , 1992, Oncogene.
[12] Alan Wells,et al. Effect of Epidermal Growth Factor Receptor Internalization on Regulation of the Phospholipase C-γ1 Signaling Pathway* , 1999, The Journal of Biological Chemistry.
[13] D A Lauffenburger,et al. Intracellular Trafficking of Epidermal Growth Factor Family Ligands Is Directly Influenced by the pH Sensitivity of the Receptor/Ligand Interaction (*) , 1995, The Journal of Biological Chemistry.
[14] Y. Yarden,et al. Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.
[15] Jie Leng,et al. ErbB2 Is Necessary for Induction of Carcinoma Cell Invasion by Erbb Family Receptor Tyrosine Kinases , 2000, The Journal of cell biology.
[16] B. Geiger,et al. Alternative Intracellular Routing of ErbB Receptors May Determine Signaling Potency* , 1998, The Journal of Biological Chemistry.
[17] D A Lauffenburger,et al. The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor. , 1991, The Journal of biological chemistry.
[18] C R King,et al. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. , 1987, Science.
[19] H. Wiley,et al. Quantitative analysis of the endocytic system involved in hormone-induced receptor internalization. , 1990, The Journal of biological chemistry.
[20] M. Sliwkowski,et al. Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness. , 1996, Cancer research.
[21] G. Assmann,et al. c‐erbB‐2/EGFR as dominant heterodimerization partners determine a motogenic phenotype in human breast cancer cells , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] C. Waters,et al. Endocytosis of growth factor receptors , 1993, BioEssays : news and reviews in molecular, cellular and developmental biology.
[23] Douglas Lauffenburger,et al. Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: quantitative analysis of HER2 overexpression effects. , 2003, Cancer research.
[24] G. Carpenter,et al. All ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis Impaired (*) , 1996, The Journal of Biological Chemistry.
[25] C. Carlin,et al. EGF receptor residues Leu679, Leu680 mediate selective sorting of ligand‐receptor complexes in early endosomal compartments , 2000, Journal of cellular physiology.
[26] E. Kornilova,et al. Lysosomal Targeting of Epidermal Growth Factor Receptors via a Kinase-dependent Pathway Is Mediated by the Receptor Carboxyl-terminal Residues 1022-1123* , 1996, The Journal of Biological Chemistry.
[27] H. Wiley,et al. ErbB-2 Amplification Inhibits Down-regulation and Induces Constitutive Activation of Both ErbB-2 and Epidermal Growth Factor Receptors* , 1999, The Journal of Biological Chemistry.
[28] J. Brugge,et al. Controlled Dimerization of ErbB Receptors Provides Evidence for Differential Signaling by Homo- and Heterodimers , 1999, Molecular and Cellular Biology.
[29] Brian Higgins,et al. Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth. , 2002, Cancer cell.
[30] J. Baselga. A new anti-ErbB2 strategy in the treatment of cancer: prevention of ligand-dependent ErbB2 receptor heterodimerization. , 2002, Cancer cell.
[31] A. Lenferink,et al. Differential endocytic routing of homo‐ and hetero‐dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers , 1998, The EMBO journal.
[32] S. Schmid,et al. Control of EGF Receptor Signaling by Clathrin-Mediated Endocytosis , 1996, Science.
[33] M. Greene,et al. Intermolecular association of the p185 neu protein and EGF receptor modulates EGF receptor function , 1990, Cell.
[34] H. Wiley,et al. Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking. , 2001, Molecular biology of the cell.
[35] R. Kurten,et al. Enhanced Degradation of EGF Receptors by a Sorting Nexin, SNX1 , 1996, Science.
[36] E. Radany,et al. erbB-2 overexpression in human mammary epithelial cells confers growth factor independence. , 1999, Endocrinology.
[37] H. Steven Wiley,et al. Regulation of Receptor Tyrosine Kinase Signaling by Endocytic Trafficking , 2001, Traffic.
[38] A Ciechanover,et al. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. , 1999, Molecular cell.
[39] A. Ullrich,et al. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells , 1987, Cell.
[40] Y. Yarden,et al. Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins. , 1996, Oncogene.
[41] D. Lauffenburger,et al. Internalized Epidermal Growth Factor Receptors Participate in the Activation of p21 ras in Fibroblasts* , 1999, The Journal of Biological Chemistry.
[42] S. Emr,et al. Endosomal localization and function of sorting nexin 1 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[43] Z. Kam,et al. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. , 1998, Genes & development.
[44] N. Hynes,et al. The biology of erbB-2/neu/HER-2 and its role in cancer. , 1994, Biochimica et biophysica acta.
[45] G. Carpenter,et al. The carboxyl terminus of epidermal growth factor receptor/erbB-2 chimerae is internalization impaired. , 1993, Oncogene.
[46] D. Lauffenburger,et al. Intracellular receptor/ligand sorting based on endosomal retention components , 1996, Biotechnology and bioengineering.
[47] R. Weinberg,et al. The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. , 1985, Science.
[48] J. Linderman,et al. Calculation of diffusion-limited kinetics for the reactions in collision coupling and receptor cross-linking. , 1997, Biophysical journal.
[49] D. Lauffenburger,et al. Regulation of postendocytic trafficking of the epidermal growth factor receptor through endosomal retention. , 1994, The Journal of biological chemistry.
[50] H. Wiley,et al. Endocytosis and Lysosomal Targeting of Epidermal Growth Factor Receptors Are Mediated by Distinct Sequences Independent of the Tyrosine Kinase Domain (*) , 1995, The Journal of Biological Chemistry.
[51] D A Lauffenburger,et al. Analysis of intracellular receptor/ligand sorting. Calculation of mean surface and bulk diffusion times within a sphere. , 1986, Biophysical journal.
[52] Y. Yarden,et al. ErbB‐2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. , 1996, The EMBO journal.
[53] C. Carlin,et al. A Leucine-based Determinant in the Epidermal Growth Factor Receptor Juxtamembrane Domain Is Required for the Efficient Transport of Ligand-Receptor Complexes to Lysosomes* , 1999, The Journal of Biological Chemistry.
[54] T. K. Yeung,et al. Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation. , 1999, Molecular biology of the cell.
[55] Monilola A. Olayioye,et al. ErbB-1 and ErbB-2 Acquire Distinct Signaling Properties Dependent upon Their Dimerization Partner , 1998, Molecular and Cellular Biology.